Hot Stocks : NXP Semiconductors NV (NASDAQ:NXPI), ON Semiconductor Corp. (NASDAQ:ONNN), Tilly’s, Inc. (NYSE:TLYS), Tesaro, Inc. (NASDAQ:TSRO), Covenant Transportation Group, Inc. (NASDAQ:CVTI)

NXP Semiconductors NV (NASDAQ:NXPI)‘s stock had its “buy” rating reiterated by stock analysts at Credit Suisse in a report issued on Friday, 03 October 2014. NXP Semiconductors NV (NASDAQ:NXPI) belongs to Technology sector. Its net profit margin is 10.10% and weekly performance is -16.37%. On last trading day company shares ended up $56.34. NXP Semiconductors NV (NASDAQ:NXPI) distance from 50-day simple moving average (SMA50) is … Continue reading Hot Stocks : NXP Semiconductors NV (NASDAQ:NXPI), ON Semiconductor Corp. (NASDAQ:ONNN), Tilly’s, Inc. (NYSE:TLYS), Tesaro, Inc. (NASDAQ:TSRO), Covenant Transportation Group, Inc. (NASDAQ:CVTI)

Chris Lewis10/1310/13

Fast Moving Stocks : LRAD Corporation (NASDAQ:LRAD), ON Semiconductor (NASDAQ:ONNN), GreenHunter Resources (NYSEMKT:GRH), Tesaro, Inc. (NASDAQ:TSRO), Alimera Sciences, Inc. (NASDAQ:ALIM)

One of the brightest Small-Cap Stars of the last month has been the San Diego-based LRAD Corporation (NASDAQ:LRAD). The company’s spiked almost 65% since the start of August following a particularly robust fiscal Q3 earnings report released after market close on August 7. The huge spike means that LRAD Corporation has currently more than doubled its market value since the start of 2014. LRAD Corporation … Continue reading Fast Moving Stocks : LRAD Corporation (NASDAQ:LRAD), ON Semiconductor (NASDAQ:ONNN), GreenHunter Resources (NYSEMKT:GRH), Tesaro, Inc. (NASDAQ:TSRO), Alimera Sciences, Inc. (NASDAQ:ALIM)

Colin Pettis09/0509/05

FB Nasdaq FB Facebook

Healthcares Week’s 20% Gainers: Chimerix Inc. (NASDAQ:CMRX), TESARO (NASDAQ:TSRO), Albany Molecular Research (NASDAQ:AMRI), Vanda Pharmaceuticals (NASDAQ:VNDA)

Chimerix Inc. (NASDAQ:CMRX) shares hit a new high on Thursday with the biotechnology firm continuing to get a boost from its decision to increase a test program for a virus-fighting drug so it can try to save a cruelly ill 7-year-old boy. Chimerix Inc. (NASDAQ:CMRX) stock performance was 2.80% in last session and finished the day at $27.14. Traded volume was 477,612.00 shares in the … Continue reading Healthcares Week’s 20% Gainers: Chimerix Inc. (NASDAQ:CMRX), TESARO (NASDAQ:TSRO), Albany Molecular Research (NASDAQ:AMRI), Vanda Pharmaceuticals (NASDAQ:VNDA)

John Bellich03/1703/17

Biotech Top Losers: TESARO Inc. (NASDAQ:TSRO), Dyax Corp. (NASDAQ:DYAX), Regulus Therapeutics (NASDAQ:RGLS), Cara Therapeutics (NASDAQ:CARA)

Tesaro Inc. (NASDAQ:TSRO) announced Thursday morning that it has entered into an exclusive, worldwide license agreement and immuno-oncology antibody collaboration with AnaptysBio Inc. TESARO Inc. (NASDAQ:TSRO) stock performance was -5.40% in last session and finished the day at $36.76. Traded volume was 732,104.00 shares in the last session and the average volume of the stock remained 469,070.00 shares. TESARO Inc. (NASDAQ:TSRO) insider ownership is 21.88%. … Continue reading Biotech Top Losers: TESARO Inc. (NASDAQ:TSRO), Dyax Corp. (NASDAQ:DYAX), Regulus Therapeutics (NASDAQ:RGLS), Cara Therapeutics (NASDAQ:CARA)

John Bellich03/1703/17

Biotech Gainers: Geron Corporation (NASDAQ:GERN), Chelsea Therapeutics International (NASDAQ:CHTP), TESARO Inc (NASDAQ:TSRO), Vanda Pharmaceuticals (NASDAQ:VNDA)

Geron Corp. (NASDAQ:GERN)‘s stock had its “positive” rating reaffirmed by equities researchers at Wells Fargo & Co. in a research report issued on Thursday, AnalystRatings.NETreports. Geron Corporation (NASDAQ:GERN) stock performance was 5.62% in last session and finished the day at $1.78. Traded volume was 16,397,352 million shares in the last session and the average volume of the stock remained 5.30 million shares. The beta of … Continue reading Biotech Gainers: Geron Corporation (NASDAQ:GERN), Chelsea Therapeutics International (NASDAQ:CHTP), TESARO Inc (NASDAQ:TSRO), Vanda Pharmaceuticals (NASDAQ:VNDA)

Mark DeFrance03/1403/14

Biotech Unusual Volume: OXiGENE Inc (NASDAQ:OXGN), TESARO Inc (NASDAQ:TSRO), Discovery Laboratories (NASDAQ:DSCO), Albany Molecular Research (NASDAQ:AMRI)

OXiGENE Inc (NASDAQ:OXGN) on Mar. 11 announced positive results from a randomized Phase 2 clinical trial evaluating Avastin(R) (bevacizumab) with or without ZYBRESTAT(R) (fosbretabulin; CA4P) to treat patients with recurrent ovarian cancer. The study, known as Gynecologic Oncology Group protocol 186I, met its primary endpoint of a statistically significant increase in progression-free survival (p-value less than 0.05; hazard ratio 0.685) for the combination as compared … Continue reading Biotech Unusual Volume: OXiGENE Inc (NASDAQ:OXGN), TESARO Inc (NASDAQ:TSRO), Discovery Laboratories (NASDAQ:DSCO), Albany Molecular Research (NASDAQ:AMRI)

Jason Knox03/1403/14